Baylis, F., & Fenton, A. (2007). Chimera research and stem cell therapies for human neurodegenerative disorders. Cambridge Quarterly of Healthcare Ethics, 16
Bazelon, D. L. (1977). Coping with technology through the legal process. Cornell Law Review, 62(817), 826–827.
Beyleveld, D., & Brownsword, R. (2001). Human dignity in bioethics and biolaw. Oxford: Oxford University Press.
Beyleveld, D., & Brownsword, R. (2006). Principle, proceduralism and precaution in a community of rights. Ratio Juris, 19
Beyleveld, D., & Brownsword, R. (2007). Consent in the law. Oxford: Hart.
Beyleveld, D., & Brownsword, R. (2009). Complex technology, complex calculations: Uses and abuses of precautionary reasoning in law. In M. Duwell & P. Sollie (Eds.), Evaluating new technologies: Methodological problems for the ethical assessment of technological developments (pp. 175–190). New York: Springer.
Beyleveld, D., & Pattinson, S. (2002). Horizontal applicability and direct effect. Law Quarterly Review, 118, 623.
Biegel, S. (2001). Beyond our control? (p. 28). Cambridge, MA: MIT.
Blackwelder, B. (2007). Nanotechnology jumps the gun: Nanoparticles in consumer products. In M. Nigel, S. de Cameron & M. E. Mitchell (Eds.), Nanoscale
(p. 71). Hoboken, NJ: Wiley.CrossRef
Bottoms, A. E., & Brownsword, R. (1982). The dangerousness debate after the Floud report. British Journal of Criminology, 22, 229–254.
Bottoms, A. E., & Brownsword, R. (1983). Dangerousness and rights. In J. Hinton (Ed.), Dangerousness: Problems of assessment and prediction (pp. 9–22). London: Allen and Unwin.
Brownsword, R. (2004). The cult of consent: Fixation and fallacy. King’s College Law Journal, 15, 223.
Brownsword, R. (2005a). Biotechnology and rights: Where are we coming from and where are we going? In M. Klang & A. Murray (Eds.), Human rights in the digital age (p. 219). London: Cavendish.
Brownsword, R. (2005b). Making people better and making better people: Bioethics and the regulation of stem cell research. Journal of Academic Legal Studies, 1, 3.
Brownsword, R. (2006). Cloning, zoning and the harm principle. In S. A. M. McLean (Ed.), First do no harm (p. 527). Aldershot: Ashgate.
Brownsword, R. (2007a). Ethical pluralism and the regulation of modern biotechnology. In F. Francioni (Ed.), The impact of biotechnologies on human rights (p. 45). Oxford: Hart.
Brownsword, R. (2007b). The ancillary care responsibilities of researchers: Reasonable but not great expectations. Journal of Law, Medicine and Ethics, 35, 679–691.
Brownsword, R. (2008a). Rights, regulation and the technological revolution
. Oxford: Oxford University Press.CrossRef
Brownsword, R. (2008b). Regulating nanomedicine—the smallest of our concerns? Nanoethics, 2
Brownsword, R. (2009). Regulating nanotechnologies: A matter of some uncertainty. Politeia (in press)
Davies, J. C. (2006). Managing the effects of nanotechnology
. Washington: Woodrow Wilson International Center for Scholars. Available at http://www.wilsoncenter.org/events/docs/Effectsnanotechfinal.pdf
(last visited August 30, 2007).
Deibert, R. J., & Villeneuve, N. (2005). Firewalls and power: An overview of global state censorship of the Internet. M. Klang & A. Murray (Eds.), Human rights in the digital age (p. 111). London: Cavendish.
Dorbeck-Jung, B. (2008). How can hybrid nanomedical products regulation cope with wicked governability problems? Presented at the TILT “Tilting Perspectives on Regulating Technologies” Conference, University of Tilburg, December 10 and 11, 2008 (on file with author).
Dupuy, J.-P. (2007). Complexity and uncertainty: A prudential approach to nanotechnology. In F. Allhoff, P. Lin, J. Moor & J. Weckert (Eds.), Nanoethics, Ch. 9 (p. 119). Hoboken, NJ: Wiley.
European Group on Ethics in Science and New Technologies to the European Commission (2007). Opinion on the ethical aspects of nanomedicine (Opinion No 21).
Farrelly, C. (2007). Deliberative democracy and nanotechnology. In F. Allhoff, P. Lin, J. Moor & J. Weckert (Eds.), Nanoethics (pp. 215–216). Hoboken, NJ: Wiley.
Gewirth, A. (1978). Reason and morality. Chicago: University of Chicago Press.
Gewirth, A. (1996). Community of rights. Chicago: University of Chicago Press.
Goldsmith, J. (1998). Against cyberanarchy. University of Chicago Law Review, 65
Guerra, G. (2008). European regulatory issues in nanomedicine. Nanoethics, 2
Harris, J. (2007). Enhancing evolution. Princeton: Princeton University Press.
Hart, H. L. A. (1973). Bentham on legal rights. In A. W. B. Simpson (Ed.), Oxford essays in jurisprudence (second series) (p. 171). Oxford: Clarendon.
Holm, S. (2005). Does nanotechnology require a new ‘nanoethics’?. Wales: CCELS.
Johnson, D. R., & Post, D. (1996). Law and borders—the rise of law in cyberspace. Stanford Law Review, 48
Klang, M. & Murray, A. (Eds.) (2005). Human rights in the digital age. London: Cavendish.
Lessig, L. (2001). The future of ideas. New York: Vintage Books.
Lessig, L. (2006). Code Version 2.0. New York: Basic Books.
Lin, A. C. (2007). Size matters: Regulating nanotechnology. Harvard Environmental Law Review, 31, 349. at 361–374.
MacCormick, D. N. (1977). Rights in legislation. In P. M. S. Hacker & J. Raz (Eds.), Law, morality, and society (p. 189). Oxford: Clarendon.
Mandel, G. N. (2008). Nanotechnology governance. Alabama Law Review, 59, 1.
Manson, N. C., & O’Neill, O. (2007). Rethinking informed consent in bioethics. Cambridge: Cambridge University Press.
Marchant, G. E., & Sylvester, D. J. (2006). Transnational models for regulation of nanotechnology. Journal of Law, Medicine and Ethics, 34
McHale, J. V. (2008). Nanomedicine—small particles, big issues: A new regulatory dawn for health care law and bioethics? In M. Freeman (Ed.), Law and bioethics (p. 376). Oxford: Oxford University Press.
Moor, J. H. (2008). Why we need better ethics for emerging technologies. In J. van den Hoven & J. Weckert (Eds.), Information technology and moral philosophy (pp. 26–39). Cambridge: Cambridge University Press.
NCB. (1999). Genetically modified crops: The ethical and social issues (p. 162). London: Nuffield Council on Bioethics.
Noah, L. (2000). Rewarding regulatory compliance: The pursuit of symmetry in products liability. Georgetown Law Journal, 88, 2147.
O’Neill, O. (2003). Some limits of informed consent. Journal of Medical Ethics, 29
Phelps, T. A. (2007). The European approach to nanoregulation. In M. Nigel, S. de Cameron & M. E. Mitchell (Eds.), Nanoscale
(p. 189). Hoboken, NJ: Wiley.CrossRef
RCEP. (2008). Novel materials in the environment: The case of nanotechnology. London: Royal Commission on Environmental Protection.
Reidenberg, J. R. (1998). Lex Informatica: The formulation of information policy rules through technology. Texas Law Review, 76, 553.
Reidenberg, J. R. (2005). Technology and Internet jurisdiction. University of Pennsylvania Law Review, 153
Sandel, M. (2007). The case against perfection. Cambridge, MA: Harvard University Press.
Sandler, R., & Kay, W. D. (2006). The national nanotechnology initiative and the social good. Journal of Law Medicine, and Ethics, 34
Spinello, R. A. (2006). Cyberethics: Morality and law in cyberspace (3rd ed.). Sudbury, MA: Jones and Bartlett.
Stewart, R. B. (2002). Environmental regulatory decision making under uncertainty. In T. Swanson (Ed.), An introduction to the law and economics of environmental policy: Issues in institutional design
(p. 71). Amsterdam: Elsevier.CrossRef
Sunstein, C. (2005). Laws of fear. Cambridge: Cambridge University Press.
ten Have, H. (2006). UNESCO and Ethics of Science and Technology. In UNESCO (Ed.), Ethics of science and technology: Explorations of the frontiers of science and ethics, 5–16, at 6. Paris: UNESCO.
van Calster, G., & Bowman, D. (2008). Sufficient or deficient? A review of the adequacy of current EU legislative instruments for regulating nanotechnologies across three industry sectors. Presented at the TILT “Tilting Perspectives on Regulating Technologies” conference, University of Tilburg, December 10 and 11, 2008 (on file with author).
van den Daele, W. (2007). Legal framework and political strategy in dealing with the risks of new technology: The two faces of the precautionary principle. In H. Somsen (Ed.), The regulatory challenge of biotechnology (p. 118). Cheltenham: Elgar.
van den Hoven, J. (2007). Nanotechnology and privacy: Instructive case of RFID. In F. Allhoff, P. Lin, J. Moor & J. Weckert (Eds.), Nanoethics (p. 253). Hoboken, NJ: Wiley.
Wardak, A., & Gorman, M. E. (2006). Using trading zones and life cycle analysis to understand nanotechnology regulation. Journal of Law, Medicine and Ethics, 34
Weckert, J., & Moor, J. (2007). The precautionary principle in nanotechnology. In F. Allhoff, P. Lin, J. Moor & J. Weckert (Eds.), Nanoethics, Ch. 10. Hoboken, NJ: Wiley.
Wilson, R. F. (2006). Nanotechnology: The challenge of regulating known unknowns. Journal of Law, Medicine and Ethics, 34
Yusuf, A. A. (2007). UNESCO standard-setting activities on bioethics: Speak softly and carry a big stick. In F. Francioni (Ed.), Biotechnologies and international human rights (p. 85). Oxford: Hart.